AMEX : FBT

First Trust NYSE Arca Biotechnology Index Fund

$258.65 USD

$0.12 (0.05%)

Volume
23.36K
Average Volume
67.63K
Market Capitalization
$1.61B
P/E Ratio
Dividend Yield
%
Price Target
Year High
$260.25
Year Low
$164.40
Day High
—
Day Low
—
Payout Ratio
Current Ratio
Company Overview

AMEX

Asset Management

Financial Services

FBT

N/A

US

USD

https://www.ftportfolios.com/Retail/Etf/EtfSummary.aspx?Ticker=FBT

1-800-621-1675

33733E203

0001329377

Liquidity Metrics

Sales & Valuation

-$

Profitability

-$

%

%

%

%

P/E Metrics

Analyst Price Target & Rating

N/A

0/5

0 Analysts

%

Financial Health Scores

No financial score data available.

Key Metrics (TTM)

No key metrics data available.

Company Executives

No executive data available.

Poll Results

No votes yet today — be the first to share your view!

About First Trust NYSE Arca Biotechnology Index Fund (AMEX:FBT) Stock

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund (ETF) designed with a clear purpose: to accurately reflect the price movements and income generated by the NYSE Arca Biotechnology Index. Its core objective is to closely match the performance of this benchmark index, before accounting for the fund's operational fees and expenses. ...

FBT and IBB Are Not the Same Biotech Bet, and 5 Years of Returns Prove It

2026-07-27 07:25:15

Biotech investors picking between the First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) and the iShares Biotechnology ETF (NASDAQ:IBB) often treat them as interchangeable proxies for the same sector.

Which Is the Better Healthcare ETF: First Trust's High-Conviction FBT or Vanguard's Low-Cost VHT?

2026-07-23 08:15:25

FBT surged 51.6% in one year but carries higher risk and costs. VHT offers broader diversification at a fraction of the expense ratio.

Which Healthcare ETF Is the Better Buy: iShares' Global IXJ or First Trust's Biotech FBT?

2026-07-21 14:12:47

iShares Global Healthcare ETF provides broad exposure to 110 global stocks while First Trust NYSE Arca Biotechnology Index Fund concentrates on 30 biotech positions. iShares Global Healthcare ETF carries a lower expense ratio of 0.40% compared to 0.55% for First Trust NYSE Arca Biotechnology Index Fund.

Which Is the Better Healthcare ETF, First Trust's Biotech-Focused FBT or State Street's Broader XLV?

2026-07-21 07:57:01

FBT delivered 52.4% returns over one year but with deeper drawdowns, while XLV's diversified approach offers lower costs and steadier performance.

Biotech ETFs: How Do FBT and IBB Match Up on Cost, Structure, and Performance?

2026-07-12 15:30:01

First Trust NYSE Arca Biotechnology Index Fund offers a more concentrated portfolio with only 30 holdings compared to the 248 positions in iShares Biotechnology ETF iShares Biotechnology ETF is the larger and more established fund, having launched in 2001 and managing $9.6 billion in assets under management First Trust NYSE Arca Biotechnology Index Fund has achieved a higher total return over both one-year and five-year horizons

Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?

2026-07-10 07:21:04

A smart beta exchange traded fund, the First Trust NYSE Arca Biotechnology ETF (FBT) debuted on 06/19/2006, and offers broad exposure to the Health Care ETFs category of the market.

Invesco Pharmaceuticals ETF or First Trust Biotech Fund: Which Drug Maker-Focused Fund Should You Buy in 2026?

2026-07-08 18:04:06

Invesco Pharmaceuticals ETF has a higher 5-year growth total of $1,563 compared to $1,480 for First Trust NYSE Arca Biotechnology Index Fund First Trust NYSE Arca Biotechnology Index Fund is more affordable with a 0.55% expense ratio while Invesco Pharmaceuticals ETF charges 0.57% Invesco Pharmaceuticals ETF experienced a lower 5-year maximum drawdown of 17.50% compared to 29.90% for the First Trust fund

Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?

2026-07-02 07:21:08

Launched on June 19, 2006, the First Trust NYSE Arca Biotechnology ETF (FBT) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the equity market.

Frequently Asked Questions

What is the current First Trust NYSE Arca Biotechnology Index Fund (FBT) stock price?

First Trust NYSE Arca Biotechnology Index Fund(AMEX:FBT) stock price is $258.65 in the last trading session. During the trading session, FBT stock reached the peak price of $260.25 while $164.4 was the lowest point it dropped to. The percentage change in FBT stock occurred in the recent session was 0.05% while the dollar amount for the price change in FBT stock was $0.12.

FBT's industry and sector of operation?

The AMEX listed FBT is part of Asset Management industry that operates in the broader Financial Services sector.

Who are the executives of FBT?

|
|
|
|
|

How many employees does FBT have?

Number of FBT employees currently stands at None. FBT operates from 120 East Liberty Drive, Suite 400, Wheaton, IL 60187, US.

Link for FBT official website?

Official Website of FBT is: https://www.ftportfolios.com/Retail/Etf/EtfSummary.aspx?Ticker=FBT

How do I contact FBT?

FBT could be contacted at phone #1-800-621-1675 and can also be accessed through its website. FBT operates from 120 East Liberty Drive, Suite 400, Wheaton, IL 60187, US.

How many shares of FBT are traded daily?

The average number of FBT shares traded daily for last 3 months was 67.63K.

What is the market cap of FBT currently?

The market value of FBT currently stands at $1.61B with its latest stock price at $258.65